WETS
GILD icon

Wealth Enhancement Trust Services’s Gilead Sciences GILD Stock Holding History

Wealth Enhancement Trust Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Sell
3,235
-87
-3% -$11.5K 0.05% 225
2026
Q1 		$463K Buy
3,322
+1,485
+81% +$208K 0.06% 205
2025
Q4 		$225K Buy
+1,837
New +$223K 0.03% 252

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wealth Enhancement Trust Services's GILD Position: Q2 2026 in Review

Wealth Enhancement Trust Services reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $11.5K and leaving 3,235 shares worth $409K. The position accounts for 0.05% of the portfolio, ranked #225.

Wealth Enhancement Trust Services first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $463K in Q1 2026. 1,763 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealth Enhancement Trust Services held 3,235 shares of Gilead Sciences worth $409K as of Q2 2026.
  • Wealth Enhancement Trust Services sold 87 Gilead Sciences shares in Q2 2026, an estimated $11.5K.
  • Gilead Sciences made up 0.05% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #225 holding.
  • Wealth Enhancement Trust Services first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Trust Services's Gilead Sciences position peaked at $463K in Q1 2026.
  • 1,763 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.